J&J/Centocor’s Remicade Gains Pediatric Crohn’s Disease Indication
Remicade is the first Crohn's disease therapy approved for pediatric patients following its May 19 supplemental BLA approval
Remicade is the first Crohn's disease therapy approved for pediatric patients following its May 19 supplemental BLA approval